| Business Summary | | National
Healthcare
Technology,
Inc.
is
a
shell
company
currently
focused
on
locating
and
consummating
a
merger
or
acquisition
with
a
private
entity.
The
Company
was
previously
engaged
in
the
development
of
Magkelate,
an
intravenous
drug
that
seeks
to
re-establish
normal
electrolyte
balance
in
ischemic
tissue
and
certain
other
products.
However,
it
was
unable
to
complete
pre-FDA
approval
testing. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | National
Healthcare
Technology,
a
development
stage
company,
is
to
seek
a
merger
or
acquisition
with
a
private
entity
after
the
Company
failed
to
market
a
intravenous
drug,
``Magkelate''.
For
the
six
months
ended
3/31/01,
the
Company
reported
no
revenues.
Net
loss
decreased
37%
to
$25
thousand.
Lower
loss
reflects
the
absence
of
a
$40
thousand
development
cost
associated
with
the
termination
of
marketing
plans
for
the
Magkelate. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | James Smith, 56 | Pres,
Director | Toni Hussain, 51 | Sec.,
Director |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|